References
- American Association of Poison Control Centers. 2011. Bath salts data. Accessed January 22, 2018. http://www.aapcc.org/dnn/Portals/0/Bath%20Salts%20Data%20for%20Website%207.07.2011.pdf.
- Ashrafioun, L., F. A. Bonadio, K. D. Baik, S. L. Bradbury, V. L. Carhart, N. A. Cross, A. K. Davis, M. Feuille, A. R. Harper, J. H. Lackey, et al. 2016. Patterns of use, acute subjective experiences, and motivations for using synthetic cathinones (“bath salts”) in recreational users. Journal of Psychoactive Drugs 48:336–43. doi:10.1080/02791072.2016.1229875.
- Boys, A., J. Marsden, and J. Strang. 2001. Understanding reasons for drug use amongst young people: A functional perspective. Health Education Research 16:457–69. doi:10.1093/her/16.4.457.
- Carhart-Harris, R. L., L. A. King, and D. J. Nutt. 2013. A web-based survey on mephedrone. Drug and Alcohol Dependence 118:19–22. doi:10.1016/j.drugalcdep.2011.02.011.
- Centers for Disease Control and Prevention. 2011. Emergency department visits after use of a drug sold as ‘bath salts’ – Michigan, November 13, 2010-March 31, 2011. Morbidity and Mortality Weekly Report 60: 2–3.
- Drug Enforcement Administration. 2017. Drugs of abuse: A DEA resource guide. Accessed January 22, 2018. https://www.dea.gov/pr/multimedia-library/publications/drug_of_abuse.pdf#page=86.
- Fass, J. A., A. D. Fass, and A. S. Garcia. 2012. Synthetic cathinones (bath salts): Legal status and patterns of abuse. Annals of Pharmacotherapy 46:436–41. doi:10.1345/aph.1Q628.
- German, C. L., A. E. Fleckenstein, and G. R. Hanson. 2014. Bath salts and synthetic cathinones: An emerging designer drug phenomenon. Life Sciences 97:2–8. doi:10.1016/j.lfs.2013.07.023.
- Gershman, J. A., and A. D. Fass. 2012. Synthetic cathinones (‘bath salts’): Legal and health care challenges. Pharmacy and Therapeutics 37 (571–572):595.
- Glantz, M. D., J. C. Anthony, P. A. Berglund, L. Degenhardt, L. Dierker, A. Kalaydjian, K. R. Merikangas, A. M. Ruscio, J. Swendsen, and R. C. Kessler. 2009. Mental disorders as risk factors for later substance dependence: Estimates of optimal prevention and treatment benefits. Psychological Medicine 39:1365–77. doi:10.1017/S0033291708004510.
- Jerry, J., G. Collins, and D. Streem. 2012. Synthetic legal intoxicating drugs: The emerging ‘incense’ and ‘bath salt’ phenomenon. Cleveland Clinic Journal of Medicine 79:258–64. doi:10.3949/ccjm.79a.11147.
- Johnson, P. S., and M. W. Johnson. 2014. Investigation of “bath salts” use patterns within an online sample of users in the United States. Journal of Psychoactive Drugs 46:369–78. doi:10.1080/02791072.2014.962717.
- Karila, L., B. Megarbane, O. Cottencin, and M. Lejoyeux. 2015. Synthetic cathinones: A new public health problem. Current Neuropharmacology 13:12–20. doi:10.2174/1570159X13666141210224137.
- Karila, L., and M. Reynaud. 2011. GHB and synthetic cathinones: Clinical effects and potential consequences. Drug Testing and Analysis 3:552–59. doi:10.1002/dta.210.
- Khey, D. N., J. Stogner, and B. L. Miller. 2014. Emerging trends in drug use and distribution. Cham, Switzerland: Springer International Publishing.
- Kuntsche, E., R. Knibbe, G. Gmel, and R. Engels. 2005. Why do young people drink? A review of drinking motives. Clinical Psychology Review 25:841–61. doi:10.1016/j.cpr.2005.06.002.
- Marinetti, L. J., and H. M. Antonides. 2013. Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: Method development, drug distribution and interpretation of results. Journal of Analytical Toxicology 37:135–46. doi:10.1093/jat/bks136.
- Miech, R. A., L. D. Johnston, P. M. O’Malley, J. G. Bachman, and J. E. Schulenberg. 2015. Monitoring the Future national survey results on drug use: 1975-2014: Overview, key findings on adolescent drug use. Ann Arbor: Institute for Social Research, The University of Michigan.
- Miller, B. L., and J. M. Stogner. 2014. Not-so-clean fun: A profile of bath salt users among a college sample in the United States. Journal of Psychoactive Drugs 46:147–53. doi:10.1080/02791072.2013.876520.
- National Institute on Drug Abuse. 2016. Cocaine. Accessed January 22, 2018. https://www.drugabuse.gov/publications/research-reports/cocaine/what-cocaine.
- National Institute on Drug Abuse. 2018. Synthetic cathinones (“Bath Salts”). Accessed January 22, 2018. https://www.drugabuse.gov/publications/drugfacts/synthetic-cathinones-bath-salts.
- Palamar, J. J. 2015. “Bath salt” use among a nationally representative sample of high school seniors in the United States. The American Journal on Addictions 24:488–91. doi:10.1111/ajad.12254.
- Prosser, J. M., and L. S. Nelson. 2012. The toxicology of bath salts: A review of synthetic cathinones. Journal of Medical Toxicology 8:33–42. doi:10.1007/s13181-011-0193-z.
- Rosenbaum, C. D., S. P. Carreiro, and K. M. Babu. 2012. Here today, gone tomorrow… and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. Journal of Medical Toxicology 8:15–32. doi:10.1007/s13181-011-0202-2.
- Spiller, H. A., M. L. Ryan, R. G. Weston, and J. Jansen. 2011. Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States. Clinical Toxicology 49:499–505. doi:10.3109/15563650.2011.590812.
- Stogner, J. M., and B. L. Miller. 2013. Investigating the ‘bath salt’ panic: The rarity of synthetic cathinone use among students in the United States. Drug and Alcohol Review 32:545–49. doi:10.1111/dar.12055.
- Weinstein, A. M., P. Rosca, L. Fattore, and E. D. London. 2017. Synthetic Cathinone and Cannabinoid designer drugs pose a major risk for public health. Frontiers in Psychiatry 8:156. doi:10.3389/fpsyt.2017.00156.
- Wiegand, T. J., P. M. Wax, T. Schwartz, Y. Finkelstein, R. Gorodetsky, and J. Brent, Toxicology Investigators Consortium Case Registry Investigators. 2012. The toxicology investigators consortium case registry – The 2011 experience. Journal of Medical Toxicology 8:360–77. doi: 10.1007/s13181-012-0264-9.
- Winstock, A., L. Mitcheson, and J. Marsden. 2010. Mephedrone: Still available and twice the price. The Lancet 376:1537. doi:10.1016/S0140-6736(10)62021-1.
- Winstock, A. R., L. R. Mitcheson, P. Deluca, Z. Davey, O. Corazza, and F. Schifano. 2011. Mephedrone, new kid for the chop? Addiction 106:154–61. doi:10.1111/j.1360-0443.2010.03130.x.
- Witteveen, E., E. J. Van Ameijden, M. Prins, and G. M. Schippers. 2007. Factors associated with the initiation of cocaine and heroin among problem drug users—Reflections on interventions. Substance Use & Misuse 42:933–47. doi:10.1080/10826080701212170.